MOLECULARINSIGHT PHARMACEUTICALS

Serial Number 77030749
606

Registration Progress

Application Filed
Oct 27, 2006
Under Examination
Oct 16, 2007
Approved for Publication
Jul 4, 2007
Published for Opposition
Jul 24, 2007
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: MOLECULARINSIGHT PHARMACEUTICALS
Previous Owner: Molecular Insight Pharmaceuticals, Inc.
Classes: 042, 044

Trademark Image

MOLECULARINSIGHT PHARMACEUTICALS

Basic Information

Serial Number
77030749
Filing Date
October 27, 2006
Published for Opposition
July 24, 2007
Abandonment Date
November 15, 2010
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 15, 2010
Classes
042 044

Rights Holder

Molecular Insight Pharmaceuticals, Inc.

03
Address
160 Second Street
Cambridge, MA 02142

Ownership History

Molecular Insight Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Molecular Insight Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
James F. Ewing

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

35 events
Date Code Type Description Documents
Jun 1, 2011 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Nov 15, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Nov 15, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 20, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 19, 2010 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 13, 2010 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 13, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 27, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 19, 2009 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 14, 2009 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 14, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2009 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 3, 2009 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 16, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 3, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 8, 2008 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 8, 2008 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 8, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 1, 2008 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 1, 2008 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 1, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 16, 2007 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 24, 2007 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 4, 2007 NPUB O NOTICE OF PUBLICATION Loading...
May 7, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 2, 2007 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 2, 2007 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 2, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 2, 2007 ALIE A ASSIGNED TO LIE Loading...
Apr 4, 2007 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 14, 2007 GPRA F PRIORITY ACTION E-MAILED Loading...
Mar 14, 2007 CPRA R PRIORITY ACTION WRITTEN Loading...
Mar 2, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 1, 2006 MDSM O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Oct 31, 2006 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Services for research and development of pharmaceutical drugs and imaging agents for medical use
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Preparation of pharmaceutical drugs and imaging agents for medical use
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the word "molecularinsight" in lowercase letters centered over the word "pharmaceuticals", which is also in lowercase letters. Three stylized disks of increasing size appear to the right of the lettering.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
MOLECULAR INSIGHT PHARMACEUTICALS

Classification

International Classes
042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"